Mineralys Therapeutics, Inc. Email Format
Biotechnology ResearchPennsylvania, United States51-200 Employees
Mineralys Therapeutics, Inc. is a biotechnology research company based in Radnor, Pennsylvania. It focuses on hypertension and aims to move beyond trial-and-error management toward personalized strategies. The company is developing lorundrostat, an investigational aldosterone synthase inhibitor, for treating hypertension, with recent data presented at ENDO 2026. As a mid-sized biotechnology firm, Mineralys seeks to address hypertension for patients and the clinical community through its work on lorundrostat. The company operates within the biotechnology research sector, focusing on cardiovascular therapies.